BridgeMD
Tests treatment safety and results for Myopia Progressing
Official title Clinical Efficacy and Mechanism Exploration of MR-61 in Delaying the Progression of Myopia
ClinicalTrials.gov ID: NCT07298824
What this study is testing
What is Investigational Bifidobacterium Preparation MR-61?
Investigational Bifidobacterium Preparation MR-61 is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for myopia progressing.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- To investigate whether probiotic MR-61 can assist in slowing down the progression rate of myopia (a prospective randomized controlled study).
- Phase 2: a mid-size study of how well it works
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 3 to 18
You may be able to join if
- Myopia is defined as spherical equivalent (SE) ≤ -0.5D.
- Aged between 3 and 18 years, with no restriction on gender.
- Cylinder power ≤ 1.50D; anisometropia of SE between both eyes ≤ 1.50D.
- The subject has sufficient compliance with the study follow-up; the subject or their guardian has the intention to receive treatment and has signed...
You likely can't join if
- Presence of other concomitant ocular diseases;
- Abnormal findings on clinical slit-lamp examination;
- Existence of amblyopia, manifest strabismus, esotropia, or other congenital ocular diseases;
- Individuals with abnormal intraocular pressure or abnormal axial length of the eye;
- Either or both parents having a spherical equivalent (SE) ≤ -6.00D;
- Other conditions inconsistent with this study.
The study team makes the final eligibility decision.
Where it's taking place
- Nanchang, Jiangxi, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 3 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nanchang, Jiangxi, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.